Status:
ACTIVE_NOT_RECRUITING
Should Ranges of Vitamin D be Redefined to Prevent or Treat Viral Infections?
Lead Sponsor:
Bursa City Hospital
Conditions:
COVID
Vitamin D Deficiency
Eligibility:
All Genders
20-80 years
Brief Summary
Blood vitamin D levels may be associated with severity of viral infections. To find out If there is a statistically significant relation between blood 25-hydroxy vitamin D (25(OH)D) levels and disease...
Detailed Description
Purpose: Vitamin D a steroid hormone has profound effects on human immunity. Active vitamin D, 1,25(OH)2D acts as an immune system modulator, preventing excessive expression of inflammatory cytokines...
Eligibility Criteria
Inclusion
- To find out vitamin D levels and it's relation with the disease severity serum 25-hydroxy-vitamin D levels, 1100 confirmed Covid-19 patients with available laboratory findings were included.
- Exlucion Criterias:
- Using immunsuppresan medical treatment. Using vitamin D or replacement history of vitamin D in last 3 months. Patients with malnutrition, immun deficiency, chronic infections, chronic other diseases such as rheumatoid arthritis, ankylosing spondilitis, lupus, hemplegia, paraplegia etc.
Exclusion
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT04394390
Start Date
May 1 2020
End Date
April 30 2025
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bursa City Hospital
Bursa, Dogankoy, Turkey (Türkiye)